Delivery Order SPE2DB20D7059-SPE2DB25FQEU1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes, valued at $42,642.60. This firm fixed-price delivery order, awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a $16,762.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin preparation used for therapeutic and cosmetic medical applications. This non-competitive delivery order, issued on June 2, 2025, with completion expected by June 24, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.70 delivery order for Xeomin 100 Unit Vials, a botulinum toxin product used for medical purposes. This competitive award, issued on August 25, 2025, carries an ultimate completion date of September 16, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, a botulinum toxin product commonly used in medical and cosmetic applications. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award to the incumbent vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin-based therapeutic product commonly used for medical and cosmetic purposes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a $26,819.52 delivery order to AmerisourceBergen Drug Corp for 200 unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. Issued on August 19, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, awarded on August 28, 2025, is set to be completed by September 19, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. As a non-set-aside competitive award, this delivery order was issued under...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used in medical and therapeutic applications. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 7, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, was competitively awarded without set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.44 to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competed award under the company's existing contract vehicle with the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQEU1Delivery Order
The Defense Logistics Agency awarded a $16,762.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This non-set-aside competitive award, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for XEOMIN supports the broader pharmaceutical supply chain requirements for military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 4/24/25 |